Translating a Trillion Points of Data into Therapies, Diagnostics, and New Insights into Disease  by Butte, Atul J.
Monday, February 17, 2014 231amutations. The bacterial SOS response system regulates DNA repair and other
pathways responsible for the cellular response to DNA damage. Among genes
upregulated during the SOS response is the umuD gene, encoding the manager
protein UmuD that subsequently undergoes self-cleavage to remove its N-ter-
minal 24 amino acids to form UmuD’. The umuD gene products are involved in
managing the cellular response to DNA damage through their interactions with
damage-bypass DNA polymerases DNA pol IV and pol V. UmuD and UmuD’
also interact with the alpha DNA polymerase and beta processivity clamp sub-
units of the replicative DNA polymerase III. We probed the interactions be-
tween UmuD or UmuD’ and the alpha polymerase subunit and determined
that the umuD gene products interact with alpha at two sites: the N-terminal
PHP domain, which is responsible for interactions with the epsilon proof-
reading subunit, and the C-terminal domain, which harbors interaction sites
for the beta clamp, the tau subunit of the clamp loader, and single-stranded
DNA (ssDNA). The C-terminal domain of alpha preferentially binds to full-
length UmuD. With FRET experiments, we subsequently showed that UmuD
but not UmuD’ inhibits the interaction between alpha and beta, suggesting
that early in the SOS response to DNA damage, UmuD could displace alpha
from the beta processivity clamp. Furthermore, optical tweezers experiments
revealed that UmuD specifically inhibits the interaction between alpha and
ssDNA. Together, these observations suggest that UmuD plays a key role in
regulating the replication fork after DNA damage.
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The discovery that the C helix of Bacteriorhodopsin exhibits spontaneous, pH-
dependent insertion to form a helix across lipid bilayers has led to the use of
related peptides, pHLIPs (pH (Low) Insertion Peptides), to study peptide inser-
tion across bilayers, to selectively target cargoes to tumors and other acidic tis-
sues in vivo, and to deliver molecules across the plasma membranes of living
cells.
Because pHLIP is unfolded on the surface of a bilayer and folding is pH-
triggered, we are able to begin to observe and understand the molecular events
that accompany the insertion and folding of a peptide entering a bilayer. When
the pH is dropped, it is found that a helix forms rapidly on the bilayer surface,
followed by a slow insertion across it in several kinetically distinct steps. The
exit pathway when the pH is suddenly raised is more rapid, and includes partial
unfolding of the helix while still in the bilayer. Lipid composition and sequence
features affect the insertion pK and pathway intermediates.
pHLIPs target acidic tissues in vivo, where the transmembrane insertion stabi-
lizes them in cells, enabling targeting of imaging and therapeutic agents. We
have shown targeting of dyes, radioisotopes, nanogold and Peptide Nucleic
Acids (PNAs) to tumors in mice, and will report on the state of our efforts to
use PNAs to suppress onco-micro RNAs, a possible route to tumor therapy.
1168-Symp
Targeting Influx Transporters in the Human Blood Brain Barrier
Kathleen Giacomini.
University of California, San Francisco, San Francisco, CA, USA.
Through its neuroprotective function, the blood-brain barrier (BBB) presents a
major challenge for the delivery of therapeutics to the central nervous system.
Critical to this function, well-described BBB efflux pumps in the ATP-binding
cassette (ABC) superfamily serve to limit drug penetration across the BBB.
Conversely, the BBB also serves in the delivery of selected nutrients, such as
vitamins and amino acids, to the central nervous system through influx trans-
porters in the Solute Carrier (SLC) superfamily. In this overview presentation,
I will describe the profiling of 359 SLC transporters in the human BBB,
comparative expression analysis with kidney and liver, and immunoassays in
brain microvessels. Several transporters previously not known to be expressed
in the BBB will be highlighted along with results from in vivo studies in ro-
dents. Several concepts will be emphasized in this presentation. In particular,
a large number of SLC transporters show enriched and high levels of expression
in the human BBB. Importantly, transporters with primary roles in drug dispo-sition in the liver and kidney are also highly enriched in the BBB. Collectively,
a dynamic view of the BBB will be presented with broad implications to the
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Whenever there is cell death, apoptotic cell free DNA fragments appear in the
circulation of the host. These fragments, typically 145-160 base pairs in size,
represent a minute fraction of total DNA in the host circulation. If care is taken
to avoid host cell breakage, the apoptotic DNA fragments can be analyzed to
provide information about the genome of the cells that produced them. In preg-
nancy, analysis of apoptotic DNA fragments has allowed the development of
very effective noninvasive aneuploidy testing. Indeed it is possible to recon-
struct the entire fetal genomic DNA sequence from these fragments. In cancer
it is possible to view copy number, sequence, and epigenetic differences be-
tween the tumor and the host by analyzing circulating free DNA. While this
work is still at early stages it is reasonable to predict that an array of useful
noninvasive cancer diagnostic tests should soon result from such studies. It is
furthermore likely that a careful search for informative apoptotic DNA frag-
ments that differ in methylation from DNA in the circulation of a normal
host might lead to methods for the early detection of other clinical situations
that are characterized by inappropriate cell death.
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There is an urgent need to translate genome-era discoveries into clinical utility,
but the difficulties in making bench-to-bedside translations have been well
described. The nascent field of translational bioinformatics may help. Dr.
Butte’s lab at Stanford builds and applies tools that convert more than a trillion
points of molecular, clinical, and epidemiological data — measured by re-
searchers and clinicians over the past decade — into diagnostics, therapeutics,
and new insights into disease. Dr. Butte, a bioinformatician and pediatric endo-
crinologist, will highlight his lab’s work on using publicly-available molecular
measurements to find new uses for drugs including drug repositioning for in-
flammatory bowel disease, discovering new treatable inflammatory mecha-
nisms of disease in type 2 diabetes, and the evaluation of patients presenting
with whole genomes sequenced.Symposium: Stochasticity in Cellular Processes
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In recent years, theoretical modeling of biochemical reaction networks has shed
light on the connection between network features (i.e., structure and dynamics)
and biological function. At the same time, the pervasiveness of stochastic fluc-
tuations in cellular processes has been amply demonstrated. These fluctuations
can fundamentally influence dynamics–for example, we found that network
models of virus evolution coupled to cellular immune responses have stochastic
steady-state distributions that are qualitatively different from those predicted by
deterministic equations. I will discuss how the features of the network that give
rise to this disparity are related to those underlying stochastic bistabilities
encountered in gene regulation and cell signaling. I will also discuss recent ad-
vances in numerical methods for inferring critical dynamical mechanisms in
complex networks, which have the potential to inform strategies for perturbing
cell dynamics.
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Spike time reliability (STR) refers to the phenomenon in which repetitive ap-
plications of a frozen copy of one stochastic signal to a neuron trigger spikes
with reliable timing while a constant signal fails to do so. Focusing on the sit-
uation in which the unstimulated neuron is quiescent but close to a switching
point for oscillations, we numerically and dynamically analyze STR treating
each noise-driven spike occurrence as a time localized event in a model neuron.
We study both the averaged properties as well as individual features of
